Literature DB >> 3287757

The protective value of vaccine-induced neutralising antibody titres in swine fever.

C Terpstra1, G Wensvoort.   

Abstract

The relationship between vaccine-induced antibody titres against swine fever virus (SFV), as measured by the neutralisation peroxidase-linked assay (NPLA), and protection against virus multiplication, excretion and transmission, disease and death was studied in 46 pigs. The pigs were housed individually and challenged intranasally with 100 pig ID50 of the virulent Brescia strain of SFV. In order to detect virus transmission, a swine fever (SF)-susceptible sentinel pig was placed in contact with the vaccinated animal 2 days after challenge. All 11 pigs with pre-challenge NPLA titres less than 12.5 responded to the challenge with fever, 8 out of 10 showed leucopenia, 7 transmitted virus to their contact and 3 died. Of the 9 animals with titres greater than or equal to 12.5 and less than 25, 8 developed fever, 6 out of 7 had leucopenia, 2 excreted and/or transmitted virus and all survived. Of the 12 pigs with pre-challenge titres greater than or equal to 25 and less than 50, 5 responded with fever, 6 out of 10 had leucopenia, 4 excreted virus and none died. Although all pigs with prechallenge titres greater than or equal to 50 showed a booster response, virus transmission was not observed, indicating that in the case of exposure such animals would not contribute towards the spread of field virus. From an epidemiological point of view, titres less than 32 were found inadequate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3287757     DOI: 10.1016/0378-1135(88)90036-3

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  22 in total

1.  Classical swine fever virus diagnostics and vaccine production in insect cells.

Authors:  M M Hulst; R J Moormann
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines.

Authors:  M N Widjojoatmodjo; H G van Gennip; A Bouma; P A van Rijn; R J Moormann
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Immunogenicity in Swine of Orally Administered Recombinant Lactobacillus plantarum Expressing Classical Swine Fever Virus E2 Protein in Conjunction with Thymosin α-1 as an Adjuvant.

Authors:  Yi-Gang Xu; Xue-Ting Guan; Zhong-Mei Liu; Chang-Yong Tian; Li-Chun Cui
Journal:  Appl Environ Microbiol       Date:  2015-03-27       Impact factor: 4.792

4.  Immunogenicity of recombinant classic swine fever virus CD8(+) T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination.

Authors:  Yigang Xu; Lichun Cui; Changyong Tian; Guocai Zhang; Guicheng Huo; Lijie Tang; Yijing Li
Journal:  Clin Vaccine Immunol       Date:  2011-09-21

5.  Plasticity of the HEK-293 cells, related to the culture media, as platform to produce a subunit vaccine against classical swine fever virus.

Authors:  Elianet Lorenzo; Lidice Méndez; Elsa Rodríguez; Nemecio Gonzalez; Gleysin Cabrera; Carlos Pérez; Rafael Pimentel; Yusmel Sordo; Maria P Molto; Talia Sardina; Alina Rodríguez-Mallon; Mario P Estrada
Journal:  AMB Express       Date:  2019-09-05       Impact factor: 3.298

6.  Effectiveness of the E2-classical swine fever virus recombinant vaccine produced and formulated within whey from genetically transformed goats.

Authors:  O Sánchez; M Barrera; O Farnós; N C Parra; E R Salgado; P A Saavedra; C D Meza; C I Rivas; M Cortez-San Martín; J R Toledo
Journal:  Clin Vaccine Immunol       Date:  2014-10-01

7.  Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera.

Authors:  M M Hulst; D F Westra; G Wensvoort; R J Moormann
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Cellular immune response to hog cholera virus (HCV): T cells of immune pigs proliferate in vitro upon stimulation with live HCV, but the E1 envelope glycoprotein is not a major T-cell antigen.

Authors:  T G Kimman; A T Bianchi; G Wensvoort; T G de Bruin; C Meliefste
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera.

Authors:  M van Zijl; G Wensvoort; E de Kluyver; M Hulst; H van der Gulden; A Gielkens; A Berns; R Moormann
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

10.  Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirus.

Authors:  R J Moormann; H G van Gennip; G K Miedema; M M Hulst; P A van Rijn
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.